Brick by Brick

Brick by Brick All Photos courtesy of iGEM and David Appleyard Now five years old, a student competition in synthetic biology embodies the struggles of the emerging discipline. By Alla Katsnelson n a November weekend, more than 800 people gathered at the Massachusetts Institute of Technology to show off six months of hard work. Each person wore one of 84 different shirts; some had a classic, young, professional design, while others ado

Written byAlla Katsnelson
| 13 min read

Register for free to listen to this article
Listen with Speechify
0:00
13:00
Share

By Alla Katsnelson

n a November weekend, more than 800 people gathered at the Massachusetts Institute of Technology to show off six months of hard work. Each person wore one of 84 different shirts; some had a classic, young, professional design, while others adopted a more playful approach-drawings of yeast having sex, for example.

Eighty-four shirts, eighty-four teams. The competition in which they were participating, called the International Genetically Engineered Machines competition, or iGEM, has a big goal: Revolutionize the engineering of biology.

An iGEM of an idea

Synthetic vaccine nabs iGEM prize

iGEM never sleeps

Video from iGEM teams

PLUS: Online-only sidebar - Standardize What?

It works like this: In the spring, teams of students from around the world, mostly undergraduates, are mailed a collection of DNA constructs, mostly made from Escherichia coli. These constructs, called biological "parts," can include simple elements, such as DNA-binding domains, or more complex ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies